OneProjects Design Innovation LimitedThursday, 25 June 2020
ByrneWallace advise OneProjects Design Innovation Limited (OneProjects), an Irish-German medical device start-up specialising in cardiac imaging innovations, in relation to its €11 million Series A fundraising to advance the development of its novel breakthrough technology in the field of cardiac imaging.
The funding will be used to advance product development, carry out clinical trials and prepare for US commercialisation of its technology. This financing round was led by LSP (Netherlands), investing from its LSP Health Economics Fund 2, and co-led by Atlantic Bridge University Fund, with participation from Enterprise Ireland and a selection of prominent MedTech entrepreneurs.
Founded in 2017, OneProjects is a privately held, venture backed medical device company based in Dublin and Munich. The company designs and develops an innovative imaging platform in the cardiac space and operates at the intersection of hardware, software and data science.
The ByrneWallace team who advised on this transaction included Catherine Dowling (Partner, Corporate & Life Sciences), Neil Keenan (Partner and Head of Corporate), and Catherine Finn (Solicitor, Corporate & Life Sciences).
For more information on this transaction and to view OneProjects’ press release, please click here.